In addition, patients in the area covered by NHS Greater Glasgow and Clyde are nearly twice as likely to die from lung cancer as a patient from the Borders.
According to the report by the Roy Castle Lung Cancer Foundation, your chance of surviving Scotland's biggest cancer killer varies depend on where you live in the country.
More than 11 people every day are killed by the disease north of the border, and more people suffer and die from the disease in the most deprived areas of Scotland, where smoking rates are also highest.
Lung cancer goes hand-in-hand with smoking and is one of Scotland's biggest killers, claiming the lives of 4055 people last year, with 90% caused by smoking.
The charity is now calling for Scottish Government bosses to investigate survival differences.
Professor Ray Donnelly, president of the Roy Castle Lung Cancer Foundation, said: "Each year, more than 4000 people die from lung cancer in Scotland – that's more than 11 people every day.
"Despite this, awareness of the signs and symptoms of lung cancer is low and more than two-thirds of patients are diagnosed at a stage when curative treatment is no longer an option.
"Once patients are diagnosed, there are significant variations across the country in treatment and outcomes. There are many reasons for these. For example, lung cancer patients from deprived areas may be more likely to have other health problems which affect their chances of surviving the disease.
"The purpose of this report is not to criticise, but to act as a catalyst to encourage those involved in managing and providing lung cancer services to look at data from their own area and examine variation. And to look for solutions to bring those areas with poorer outcomes up to the standard of the very best in order to improve the experience of lung cancer patients and save lives."
Sufferers are also more than twice as likely to survive if they live in the Borders than they are in Ayrshire and Arran.
The charity says Scotland "lags behind" other countries when it comes to beating the illness.
The country has a low five-year survival rate for lung cancer, compared to similar countries in western Europe such as Norway, Sweden and Finland.
Only 30% of lung cancer patients live one year after diagnosis, compared to 94% of breast cancer patients, 93% of prostate cancer patients and 75% of bowel cancer patients. Nearly two-thirds are not expected to survive a year.
The report, Explaining Variations in Lung Cancer in Scotland, was launched at Holyrood yesterday.